Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Psyence Biomedical Ltd PBM

Healthcare Biotechnology


NDAQ:PBM - Post by User

Psyence Biomedical Ltd
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(297)
•••
Post by whytestockson Dec 06, 2024 11:30am
23 Views
Post# 36349321

Psyence Group Enters into Agreements with its NASDAQ-Listed

Psyence Group Enters into Agreements with its NASDAQ-Listed
BREAKING NEWS: $PBM Psyence Group Enters into Agreements with its NASDAQ-Listed Associate, Psyence Biomedical, to settle outstanding obligationsTORONTO, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Psyence Group Inc (" Psyence Group " or the " Company ") (CSE: PSYG) hereby announces that it has entered into an addendum to the previously announced debt-for-equity swap agreements (the " Debt Swap Agreements ") with its NASDAQ-listed assoc...PBM - Psyence Group Enters into Agreements with its NASDAQ-Listed Associate, Psyence Biomedical, to settle outstanding obligations

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities